KIAA0513

Across TCGA pan-cancer cohorts, KIAA0513 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated KIAA0513 data layer compared with 21 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher KIAA0513 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated KIAA0513 expression acts as an unfavorable survival marker, although some lineages such as PDAC and HNSC show a favorable association.

PDAC, LUAD, and HNSC are the cancer types where KIAA0513 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Median	All	0.507	0.304	<.001	98	view →
LUAD	DFS	Median	III,IV	0.230	0.738	.003	22	view →
HNSC	DFS	Quartile	All	1.000	0.197	.038	12	view →
GBM	DFS	Tertile	All	0.803	0.673	.028	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

KIAA0513–PDAC (DFS)

Open the PDAC breakdown →